NCT05849038View on ClinicalTrials.gov

Inflammation and Depression in People With HIV

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
HIVDepressionAnhedonia
Interventions
DRUG

Baricitinib

Patients will receive baricitinib at a dose of 2 mg oral daily.

OTHER

Placebo

A placebo is a sugar pill that has no therapeutic effect and will be administered orally. Participants will receive 1 placebo tablet matching the baricitinib tablet.

Trial Locations (2)

30303

RECRUITING

Grady Memorial Hospital, Atlanta

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER